CONCERTA (Methylphenidate HCL)54mg*Jassen

CONCERTA (Methylphenidate HCL)54mg*Jassen

CONCERTA is a drug classified under methylphenidate that its used for the treatment of  attention deficit disorder (ADD)  and attention deficit hyperactivity disorder.Its also used to treat narcolepsy (sleep disorder)its active in the body for 12 hours. Concerta  also has the potential for nonmedical used for its stimulant .

CONCERTA  is indicated as part of a global management of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years and older, when corrective measures alone are insufficient. Treatment should be followed by a specialist in childhood behavioral disorders. The diagnosis must be established according to the criteria of the DSM or the recommendations of the ICD in force and must be based on the anamnesis and on a complete evaluation of the patient. The diagnosis cannot be based solely on the presence of one or more symptoms.

The precise etiology of this syndrome is unknown and there is no single diagnostic test. For an appropriate diagnosis, it is necessary to use medical, educational, social and psychological information.

Usually, comprehensive care includes psychological, educational and social measures, as well as medication that aims to stabilize children with behavioral disorders characterized by symptoms that may include: a history of attention disorders (attention limited) inability to concentrate, emotional lability, impulsivity, moderate to severe hyperactivity, minor neurological signs and abnormal EEG. Learning abilities can be impaired.

CONCERTA  treatment is not indicated in all children with ADHD and the decision to use this medication should be based on a thorough assessment of the severity and chronicity of the child’s symptoms, taking into account his age.

Appropriate educational support is essential and psychosocial intervention is generally necessary. When corrective measures alone prove insufficient, the decision to prescribe a psychostimulant should be based on a rigorous assessment of the severity of the child’s symptoms. Methylphenidate should always be used for the authorized indication

 

Dosage : 

Doses may be increased in 18 mg increments at weekly intervals for patients who have not achieved an optimal response at a lower dose. Daily dosages above 54 mg in children and 72 mg in adolescents have not been studied and are not recommended. Daily dosages above 72 mg in adults are not recommended.

A 27 mg dosage strength is available for physicians who wish to prescribe between the 18 mg and 36 mg dosages.

 

Side effects :

Concerta (methylphenidate extended release tablets) is a central nervous system stimulant used for treating attention deficit hyperactivity disorder (ADHD). Side effects of Concerta include:

– stomach pain,
– loss of appetite,
– headache,
– dry mouth,
– nausea,
– vomiting,
– sleep problems (insomnia),
– anxiety,
– dizziness,
– weight loss,
– irritability,
– vision problems,
– skin rash,
– nervousness,
numbness/tingling/cold feeling in the hands or feet, and
sweating.
Chronic use of Concerta may lead to dependency. Severe depression may occur upon discontinuation of Concerta.